The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL

NCT07514169 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Large B-Cell Lymphoma (LBCL)

Interventions

DRUG: Pola-ZR-Glo (Polatuzumab Vedotin, Zanubrutinib, Lenalidomide and Glofitamab) regimen

Sponsor

Ruijin Hospital